Once the deal between NBC Universal and Comcast closes, Jeff Zucker will be leaving his post as the TV network and cable giant. So what does this mean for NBC?
Like any marriage, the merger between the two airline giants has qualities that complements the others. But also like any marriage, economists predict some tough talks will be had to settle issues such as a pilots' pay.
Shareholders of United and Continental airlines have been voting for a few weeks now. We're going to get the results today on whether the two will merge to create the world's biggest airline. Tony Arnold reports on what the merger would mean for the airline industry.
Shareholders of United and Continental Airlines will vote on the airlines' proposed merger. Reporter Nancy Marshall Genzer talks with Bill Radke about why these two airlines want to merge and how effective these types of mergers are.
Burger King is going private for the second time in eight years. Being a private company may give time for the company to rejuvenate the brand, or the new investors can just borrow and not invest money into the company, like the last time.
The travel industry was hit hard by the recession. But rental car companies Hertz and Avis are putting up a fight for another rental company Dollar Thrifty.
Burger King has agreed to be acquired by the investment firm 3G Capital for a little over $3.5 billion. Steve West, vice president of Stifel Nicolaus, talks with Steve Chiotakis about why the fast food giant is so pumped to go private and how it could change the restaurant.
Comcast bought NBC Universal, which owns a chunk of online TV site Hulu, earlier this year. The deal has yet to be approved by the FTC, but cable companies are already strategizing how to incorporate online TV into their business plans.
Many companies are sitting on cash they hoarded during the recession. For some companies entertaining mergers, selling now may be a way to get the best price in case of a double-dip recession.
French pharmaceutical drug giant Sanofi-Aventis says it wants to buy the U.S. drug company Genzyme for more than $18 billion. The French are turning up the pressure for the deal, after the Americans rejected a smaller offer earlier this summer. Kyle James reports from Berlin.
